Xilio Therapeutics, Inc. (XLO)
Xilio Therapeutics, Inc. operates as a biotechnology company. It focuses on harnessing the immune system to achieve deep and durable clinical responses in cancer. The company uses its proprietary geographically precise solutions platform to rapidly engineer novel molecules, including cytokines and other biologics. Xilio Therapeutics was founded by John C. Williams and Ulrich Rodeck in June 2015 and is headquartered in Waltham, MA.
Address
828 WINTER STREET
WALTHAM, MA 02451
Founded
2015
Number of Employees
73
Website
http://www.xiliotx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)